NT-proANP、NT-proBNP和NT-proCNP对心力衰竭患者心源性事件预后预测价值的比较

被引:16
|
作者
吴超 [1 ]
赵雪燕 [1 ]
袁晋青 [1 ]
杨跃进 [1 ]
机构
[1] 中国医学科学院北京协和医学院国家心血管病中心阜外医院冠心病中心
基金
国家重点研发计划;
关键词
心力衰竭; 氨基末端A型利钠肽; 氨基末端B型利钠肽; 氨基末端C型利钠肽; 预后;
D O I
10.16563/j.cnki.1671-6272.2021.06.008
中图分类号
R541.6 [血液循环衰竭];
学科分类号
1002 ; 100201 ;
摘要
目的比较氨基末端A型利钠肽(amino-terminal A-type natriuretic peptide, NT-proANP)、氨基末端B型利钠肽(amino-terminal B-type natriuretic peptide, NT-proBNP)和氨基末端C型利钠肽(amino-terminal C-type natriuretic peptide, NT-proCNP)对心力衰竭患者预后的预测价值。方法入选112例心力衰竭患者,入院测定NT-proANP、NT-proBNP和NT-proCNP的血浆浓度。心源性事件定义为心源性死亡、心力衰竭再住院及心脏移植。通过受试者工作特征(receiver operating characteristic, ROC)曲线下面积(area under the ROC curve, AUC)比较NT-proANP、NT-proBNP和NT-proCNP对心源性事件的预后预测价值。采用多因素Cox回归模型评估心源性事件的相关影响因素。结果 112例患者平均随访(16.75±6.32)个月,共发生心源性事件30例。心源性事件组(n=30)的NT-proANP、NT-proBNP均较无心源性事件组(n=82)显著升高(P均<0.01),NT-proCNP虽有升高的趋势,但无统计学差异(P> 0.05)。NTproANP、NT-proBNP和NT-proCNP区分心源性事件的AUC分别为0.742(95%CI:0.634~0.850,P <0.001),0.772(95%CI:0.673~0.871,P <0.001)和0.569(95%CI:0.444~0.693,P=0.265)。多因素Cox分析,log(NT-proBNP)[B(SE):1.103(0.539),P=0.041]和左室射血分数(left ventricular ejection fraction, LVEF)[B(SE):-0.042(0.021),P=0.046]是心源性事件的独立影响因素,而NT-proANP和NTproCNP与心源性事件无独立相关性。结论 NT-proANP和NT-proBNP对心源性事件具有预测价值。而NT-proBNP和LVEF是心源性事件的独立影响因素。NT-proCNP对心力衰竭患者的预测价值不佳。
引用
收藏
页码:3949 / 3952
页数:4
相关论文
共 9 条
  • [1] Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure
    Khanam, Sayma Sabrina
    Choi, Eunhee
    Son, Jung-Woo
    Lee, Jun-Won
    Youn, Young Jin
    Yoon, Junghan
    Lee, Seung-Hwan
    Kim, Jang-Young
    Ahn, Sung Gyun
    Min, Min-Soo
    Kang, Seok-Min
    Baek, Sang Hong
    Jeon, Eun-Seok
    Kim, Jae-Joong
    Cho, Myeong-Chan
    Chae, Shung Chull
    Oh, Byung-Hee
    Choi, Dong-Ju
    Yoo, Byung-Su
    [J]. PLOS ONE, 2018, 13 (11):
  • [2] Neurohormonal activation in heart failure with reduced ejection fraction
    Hartupee, Justin
    Mann, Douglas L.
    [J]. NATURE REVIEWS CARDIOLOGY, 2017, 14 (01) : 30 - 38
  • [3] Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction
    Lok, Dirk J.
    Klip, IJsbrand T.
    Voors, Adriaan A.
    Lok, Sjoukje I.
    de la Porte, Pieta W. Bruggink-Andre
    Hillege, Hans L.
    Jaarsma, Tiny
    van Veldhuisen, Dirk J.
    van der Meer, Peter
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (09) : 958 - 966
  • [4] BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review
    Santaguida, Pasqualina L.
    Don-Wauchope, Andrew C.
    Oremus, Mark
    McKelvie, Robert
    Ali, Usman
    Hill, Stephen A.
    Balion, Cynthia
    Booth, Ronald A.
    Brown, Judy A.
    Bustamam, Amy
    Sohel, Nazmul
    Raina, Parminder
    [J]. HEART FAILURE REVIEWS, 2014, 19 (04) : 453 - 470
  • [5] Amino-terminal Fragment of C-type Natriuretic Peptide Precursor and C-type Natriuretic Peptide Do Not Correlate in Patients With Chagas Disease: Role For Neutral Endopeptidase
    Wang, Yong
    Moreira, Maria da Consolacao V.
    Heringer-Walther, Silvia
    Schultheiss, Heinz-Peter
    Siems, Wolf-Eberhard
    Wessel, Niels
    Walther, Thomas
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (01) : 62 - 66
  • [6] Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides..[J].Moreira Maria da Consolação V;Wang Yong;Heringer-Walther Silvia;Wessel Niels;Walther Thomas.Congestive heart failure (Greenwich, Conn.).2009, 2
  • [7] Does the C-type natriuretic peptide have prognostic value in Chagas disease and other dilated cardiomyopathies
    Heringer-Walther, Silvia
    Moreira, Maria da Consolacao V.
    Wessel, Niels
    Wang, Yong
    Ventura, Pago Moreira
    Schultheiss, Heinz-Peter
    Walther, Thomas
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 48 (06) : 293 - 298
  • [8] Amino-terminal pro-C-type natriuretic peptide in heart failure..[J].Wright Sue P;Prickett Tim C R;Doughty Robert N;Frampton Chris;Gamble Greg D;Yandle Tim G;Sharpe Norman;Richards Mark.Hypertension (Dallas, Tex. : 1979).2004, 1
  • [9] PROGNOSTIC IMPORTANCE OF ATRIAL NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC HEART-FAILURE
    GOTTLIEB, SS
    KUKIN, ML
    AHERN, D
    PACKER, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (07) : 1534 - 1539